Erste Asset Management Gmb H Vertex Pharmaceuticals Inc Transaction History

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

A detailed history of Erste Asset Management Gmb H transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Erste Asset Management Gmb H holds 63,514 shares of VRTX stock, worth $29.7 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

63,514

Holding current value

$29.7 Million

% of portfolio

0.35%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $29.2 Million - $32.1 Million	63,514 New	63,514 $29.4 Billion
Q2 2024 Nov 26, 2024	SELL	$392.81 - $485.53 $3.3 Million - $4.07 Million	-8,392 Reduced 12.58%	58,306 $27.6 Billion
Q1 2024 Nov 26, 2024	SELL	$407.69 - $446.08 $18.4 Million - $20.2 Million	-45,233 Reduced 40.41%	66,698 $27.8 Billion
Q4 2023 Nov 26, 2024	SELL	$343.0 - $410.68 $1.13 Million - $1.35 Million	-3,294 Reduced 2.86%	111,931 $45.7 Billion
Q3 2023 Nov 26, 2024	BUY	$338.18 - $362.46 $11.2 Million - $12 Million	33,095 Added 40.3%	115,225 $40.5 Billion
Q2 2023 Nov 26, 2024	SELL	$314.42 - $351.91 $1.15 Million - $1.29 Million	-3,655 Reduced 4.21%	83,075 $28.9 Billion
Q1 2023 Nov 26, 2024	BUY	$283.23 - $323.1 $1.19 Million - $1.36 Million	4,207 Added 5.1%	86,730 $27.1 Billion
Q4 2022 Nov 26, 2024	SELL	$285.76 - $321.48 $755,263 - $849,671	-2,643 Reduced 3.12%	82,130 $23.7 Billion
Q3 2022 Nov 26, 2024	BUY	$273.83 - $305.53 $5.21 Million - $5.81 Million	19,009 Added 29.93%	82,523 $24.2 Billion
Q2 2022 Nov 26, 2024	SELL	$234.96 - $292.55 $31.5 Million - $39.2 Million	-133,927 Reduced 61.24%	84,773 $23.8 Billion
Q1 2022 Nov 22, 2024	BUY	$221.42 - $260.97 $4.87 Million - $5.74 Million	22,000 Added 35.48%	84,000 $21.6 Billion
Q4 2021 Nov 22, 2024	SELL	$177.01 - $223.45 $409,601 - $517,063	-2,314 Reduced 3.64%	61,200 $13.7 Billion
Q2 2021 Nov 22, 2024	SELL	$187.49 - $221.1 $1.43 Million - $1.69 Million	-7,640 Reduced 10.97%	62,000 $12.2 Billion
Q4 2020 Nov 22, 2024	BUY	$207.01 - $276.09 $1.6 Million - $2.14 Million	7,738 Added 12.5%	69,640 $16.3 Billion
Q3 2020 Nov 22, 2024	SELL	$255.65 - $303.1 $412,107 - $488,597	-1,612 Reduced 2.54%	61,902 $16.7 Billion
Q2 2020 Nov 22, 2024	SELL	$225.48 - $295.8 $5.13 Million - $6.73 Million	-22,750 Reduced 24.89%	68,650 $19.6 Billion
Q1 2020 Nov 22, 2024	BUY	$199.77 - $247.81 $1.9 Million - $2.35 Million	9,500 Added 11.6%	91,400 $21.2 Billion
Q4 2019 Nov 22, 2024	BUY	$166.71 - $223.91 $3.07 Million - $4.12 Million	18,386 Added 28.95%	81,900 $18.1 Billion
Q3 2019 Nov 22, 2024	SELL	$166.23 - $187.09 $1.51 Million - $1.7 Million	-9,100 Reduced 4.12%	211,900 $35.7 Billion
Q2 2019 Nov 22, 2024	BUY	$164.61 - $190.37 $3.01 Million - $3.48 Million	18,300 Added 9.03%	221,000 $40.1 Billion
Q1 2019 Nov 22, 2024	BUY	$163.73 - $194.7 $22.8 Million - $27.1 Million	139,186 Added 219.14%	202,700 $37.2 Billion
Q4 2018 Nov 26, 2024	BUY	$151.91 - $192.21 $23.6 Million - $29.8 Million	155,186 Added 244.33%	218,700 $35.4 Billion

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Vertex Pharmaceuticals Inc Transaction History